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Abstract
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Caused by a microdeletion at the q11.2 locus of chromosome 22, velo-cardio-facial syndrome
(also known as VCFS, 22q11 deletion syndrome, DiGeorge sequence, and conotruncal anomalies
face syndrome) is associated with a distinctive physical, neurocognitive and psychiatric
phenotype. Increasing interest has centered on identifying the candidate genes within the deleted
region that may contribute to this phenotype. One attractive candidate gene is catechol-Omethyltransferase (COMT) because it encodes for a protein that degrades dopamine. COMT
activity is variable related to a Val158Met polymorphism that has been implicated in prefrontal
lobe cognitive and neuropsychiatric function. We examined the effect of this polymorphism on
prefrontal anatomy and frontally-mediated neuropsychological function in 58 children with VCFS,
26 who were hemizygous for the Met allele and 32 for the Val allele. We found an allele by
gender interaction effect on the volumes of the dorsal prefrontal and orbital prefrontal cortices. We
did not find significant allele or gender by allele effects on neuropsychological tasks, although
girls with the Met allele tended to perform better on the Wisconsin Card Sorting Task. These data
suggest that this functional COMT polymorphism may play a gender-moderated role in
determining the neuroanatomic phenotype of individuals with VCFS. Longitudinal evaluation of
these children is essential in order to identify potential clinical implications of this allele by gender
interaction.
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Introduction
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Velocardiofacial syndrome, caused by an interstitial microdeletion of more than 40 genes on
one copy of chromosome 22, is associated with heart malformations, palate anomalies,
learning disabilities and behavioral disorders (Goldberg et al., 1993; Shprintzen et al., 1978).
Individuals with VCFS exhibit a distinct neuropsychological and psychiatric phenotype, and
frequently display deficits in executive function, working memory, visual-spatial abilities
and abstract thinking (Bish et al., 2005; Henry et al., 2002; Simon et al., 2005; Sobin et al.,
2004; Van Amelsvoort et al., 2004). Relative to other children with learning / developmental
disorders, children with VCFS have significantly higher rates of attention deficit
hyperactivity disorder, specific phobias, and in some samples, major depressive disorder
(Arnold et al., 2001; Feinstein et al., 2002). Schizophrenia and other psychoses have been
reported to be clinical features of VCFS and the rate of psychosis may be as high as 20% 25%. (Bassett and Chow, 1999; Murphy et al., 1999; Pulver et al., 1994; Shprintzen et al.,
1992). Although we do not fully understand the mechanisms that produce this phenotype in
VCFS, several of the genes that are located within the 22q11.2 deleted region have been
associated with working memory, executive function, and the occurrence of schizophrenia in
the general population (Egan et al., 2001; Goldberg et al., 2003; Li et al., 2004; Liu et al.,
2002a; Liu et al., 2002b; Meyer-Lindenberg et al., 2005; Shiffman et al., 2004; Shifman et
al., 2002).
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One gene that has been implicated in neurocognition and psychiatric status is the catecholO-methyltransferase gene (COMT). This gene encodes for a protein that degrades
catecholamines, including dopamine. COMT is located within the 22q11.2 region that is
deleted in children with VCFS. One of the polymorphisms of this gene is the Val158Met
polymorphism. The activity of the Met allele in the prefrontal cortex is about 40% lower
than the activity of the Val allele (Chen et al., 2004), resulting in decreased dopamine
degradation and increased availability of dopamine at the synaptic clefts. Presumably due to
its expression in the prefrontal cortex (Matsumoto et al., 2003), variation on the Val158Met
polymorphism is associated with performance on neuropsychological tasks of working
memory and executive function (Diamond et al., 2004; Egan et al., 2001). In addition,
several studies have linked COMT haplotypes containing this polymorphism to risk for
schizophrenia and bipolar disorder in the general population (Shiffman et al., 2004; Shifman
et al., 2002), although these findings are not consistent (Funke et al., 2005) and have been
challenged by recent reports (see review, Fan et al., 2005).
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Because individuals with VCFS only have one COMT gene, the availability of synaptic
dopamine is already compromised. We do not know what effect hemizygosity of the COMT
gene has on catecholamine neurotransmission and consequent brain function in individuals
with VCFS. There are relatively few published studies of the effect of hemizygosity for the
Met or the Val allele on the psychiatric or neuropsychological phenotype in VCFS. Papolous
and colleagues (1996) found an association between the Met allele and the presence of
bipolar disorder in adolescents and adults with VCFS. Bearden and coworkers, in
evaluations of the behavioral and neuropsychological functioning of children and youth with
VCFS, found that individuals with the Met allele exhibited fewer behavioral problems and
better performance on tasks of executive function (Bearden et al., 2004; Bearden et al.,
2005). Based on a longitudinal study of 24 adolescents with VCFS, Gothelf and colleagues
(2005) recently identified the Met allele as a risk factor for decline in prefrontal volumes and
verbal IQ, and increase in psychotic symptoms. The apparent discrepancy in these findings
is probably not surprising given the relatively small impact that a single gene might have on
behavior, particularly in a disorder characterized by the microdeletion of multiple genes,
several of which may be affecting (in conjunction with environmental factors) cognition
and / or psychiatric symptoms. Accordingly, it may be fruitful to investigate
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endophenotypes (e.g., biologically-driven features that may be more closely associated with
genetic variation) (Durston et al., 2005). Neuroanatomy is one such endophenotype. We
have previously shown gender differences in volumes of the dorsolateral prefrontal cortex in
a relatively small sample of children with VCFS (Kates et al., 2005). However, we did not
have COMT genotyping data available for that report.
Here, we compare the effect of variation in the COMT polymorphism on volumes of the
dorsal and orbital aspects of the prefrontal cortex in children with VCFS. Based on our
previous findings, we explore the effect of gender on the association between COMT and
prefrontal volumes. In addition, we explore the effect of this polymorphism on performance
on tasks of executive function and working memory, both associated with the dorsolateral
prefrontal cortex, and a task of response inhibition, thought to be associated with the orbital
prefrontal cortex. We hypothesized that in VCFS, variation in the Val158Met polymorphism
will be associated with prefrontal volumes. In light of previously inconclusive findings of an
association between genotype and behavior in VCFS, and evidence that behavior may not be
as closely associated with genetic variation as neuroanatomy (Hariri & Weinberger, 2003),
we hypothesized that variation in the Val158Met polymorphism is not necessarily associated
with performance on neurocognitive tasks.

Methods
NIH-PA Author Manuscript

Participants
The sample of children on whom we currently have genotype data is a subsample of children
involved in a longitudinal study of biomarkers for psychosis in VCFS (Antshel et al., 2005b;
Kates et al., 2005; Kates et al., in press). The sample for the current report consisted of 26
girls (Mean Age = 11.0, SD = 2.5; range 6 – 15) and 32 boys (Mean Age = 11.1, SD = 2.9;
range 6 – 15) with VCFS. Eleven (42%) girls and fifteen (47%) boys were hemizygous for
the Met allele. With the exception of two boys who were Asian (one hemizygous for Met,
the other for Val) and two boys who were African-American (one hemizygous for Met, the
other for Val), all children were Caucasian. Sixteen (28%) of the children were taking
psychotropic medications at the time of their participation, primarily stimulants or mood
stabilizers (See Table 1 for gender / allele breakdown). Children were recruited from the
Center for the Diagnosis, Treatment, and Study of VCFS at SUNY Upstate Medical
University. Only children with a Fluorescent In Situ Hybridization (FISH) confirmed
deletion in the 22q11.2 region of chromosome 22 were included in the sample. Children
with intractable seizure disorder, traumatic brain injury or pre-term birth were excluded
from participation. All participants provided informed consent based on guidelines of the
SUNY Upstate Institutional Review Board.
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COMT Genotyping
Samples were genotyped in duplicate by sequencing or the ABI PRISM 5′nuclease assay
(TaqMan®). For sequencing, PCR products spanning the Val158Met variant were generated
using the primers ValMet-F (5′ ctcatcaccatcgagatcaa) and ValMet-R (5′
gatgaccctggtgatagtgg) as previously described (Lachman et al., 1996). For the ABI 5′
nuclease assay, TaqMan® primers and probes were designed using the Primer Express®
Oligo Design software v2.0 (ABI PRISM) or using the ABI Assays-By-Design service. PCR
amplification was carried out on 5-20 ng DNA using 1 X TaqMan® universal PCR master
mix (No Amp-erase UNG), 900nM forward and reverse primers, 200nM of the FAM labeled
probe and 200nM of the VIC labeled probe in a 5ul reaction volume. Amplification
conditions on an AB 9700 dual plate thermal cycle (Applied Biosystems, Foster City, CA)
were as follows: 1 cycle of 95°C for 10min, followed by 50 cycles of 92°C for 15s and 58°C
for 1 min.
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MRI Imaging Acquisition and Measurement
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Magnetic resonance imaging scans were acquired in the axial plane on a 1.5 T Philips
Gyroscan scanner (Philips Medical Systems, Best, The Netherlands), utilizing the following
T-1 weighted inversion recovery 3-D pulse sequence: TE = 4.6; TR = 20; 2 repetitions;
matrix size 256 X 154; FOV 24; multishot = 32; TFE pre IR shortest (394 ms), 1.5 mm slice
thickness. We were unable to acquire scans on 7 of the boys (3 with the Met allele; 4 with
the Val allele) due to their relatively young age (all were between the ages of 7 and 9 years)
and their inability to lie still in the scanner. (The gender breakdown of children on whom we
acquired MRI data is presented in Table 2.)
Raw, formatted image data were transferred from the MRI scanner to Apple Macintosh
Power PC workstations via existing network connections. The image data were imported
into the program BrainImage (A.L. Reiss, Stanford University, 2002) for removal of nonbrain tissue and measurement of whole brain volume. The isolated brain tissue was then
transferred to the software program Measure (Barta et al., 1997) for regional volumetric
measurement. After aligning the 3D images along the anterior-posterior commissures and
interhemispheric fissure, the amygdala, hippocampus, and subregions of the prefrontal
cortex were isolated.
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The protocol for measuring subregions of the prefrontal cortex, including its dorsal and
orbital subregions, was adapted from Gur and coworkers (Gur et al., 2000) and has been
described previously (Kates et al., 2005). Interrater reliability, assessed with the intraclass
correlation coefficient, exceeded .90. Neuroanatomic raters were blind to COMT status and
gender for all volumetric measures.
Cognitive, neuropsychological, and psychiatric assessment
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Overall intellectual functioning was assessed with the Wechsler Intelligence Scale for
Children, 3rd Edition (Wechsler, 1991). Working memory was assessed with the Visual
Span Test (Davis and Keller, 1998). This test is similar to the Corsi Block Tapping Test
(Milner, 1971), and consists of an irregular array of squares displayed on the screen; a subset
of the blocks are illuminated briefly and the child must reproduce these sequences of
increasing length. Scores for forward and backward memory span were obtained. Executive
function was assessed with the Wisconsin Card Sorting Test (WCST) (Heaton, 1983). We
used the standard scores for total trials to first category and for perseverative errors for the
current set of analyses. Sustained attention was assessed with a standardized continuous
performance task, the Gordon Diagnostic System (Gordon, 1983; McClure and Gordon,
1985). This task requires the child to respond (press a button) each time a “9” follows a “1”
on a computer screen. Our primary outcome variables from the continuous performance task
were errors of omission (the child failed to respond when he/she needed to respond), errors
of commission (the child responded when he / she should not have responded), and total
reaction time (which Stefanis and colleagues [2005] have recently reported vary as a
function of COMT status). Psychiatric function was assessed with the Schedule for
Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime
Version (K-SADS-PL) (Kaufman et al., 1997). Data on the WISC-III and the K-SADS-PL
for the entire longitudinal study sample (including the children on whom we have genotype
data) are reported elsewhere (Antshel et al., in press; Antshel et al., 2005a).
Planned Analyses
Two-factor analyses of variance and covariance were conducted in order to investigate allele
and gender effects on brain volumes and on neuropsychological performance. Whole brain
volume was entered as a covariate in analyses of brain volumes. Full-scale IQ scores were
entered as a covariate in all analyses of neurocognitive performance.
Am J Med Genet B Neuropsychiatr Genet. Author manuscript; available in PMC 2008 October 8.
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We have examined a total of 58 subjects in this study. Data on age, intellectual function,
medication use and psychiatric status are presented in Table 1. Age did not vary as a
function of gender or COMT allele. Children who were taking medication did not differ
from non-medicated children by either gender or COMT allele (Fisher's Exact Test, p = .
14,.77, respectively). Similarly, children with a DSM-IV diagnosis did not differ from those
without a DSM-IV diagnosis by either gender or COMT allele (Fisher's Exact Test, p = .58, .
19, respectively). The FSIQ of girls with the Met allele was significantly higher than boys
with the Met allele (F [1,24] = 5.24; p = .03). No IQ differences were found between girls
and boys who were hemizygous for the Val allele.
Effect of gender and allele on brain morphology
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Data on brain morphology from this cohort of patients are presented in Table 2. Whole brain
volume was entered as a covariate in all analyses. Analyses of covariance revealed that
whole brain volume accounted for a significant portion of the variance, and that neither
dorsal nor orbital prefrontal volumes varied as a function of COMT status or gender alone.
However, a gender by allele interaction effect was found for both dorsal [F (4,46) = 11.69, p
< .001, η2 = .20] and orbital [F (4,46) = 17.26, p < .000, η2 = .27] prefrontal volumes. As
shown in Table 2, girls who were hemizygous for the Met allele and boys who were
hemizygous for the Val allele exhibited larger dorsal prefrontal volumes, and smaller orbital
frontal volumes than girls hemizygous for the Val allele and boys hemizygous for the Met
allele. (See Figures 1 and 2.)
Neither allele nor allele by gender effects were found for volumes of the total prefrontal
cortex (derived from the sum of the dorsal and orbital prefrontal volumes) or whole brain
volume.
Effect of gender and allele on prefrontal-based neuropsychological tasks
Data on performance on tests of neuropsychological function are presented in Table 3. Since
FSIQ is lower in boys than girls in our overall sample (Antshel et al., 2005a), and is lower in
boys with the Met allele in this subsample, FSIQ was entered as a covariate in all analyses
of neuropsychological function. Neither allele nor allele by gender effects were found for
performance on tasks of visual working memory or sustained attention. A gender effect was
found for the continuous performance task, with girls making fewer errors of commission
than boys [F (3,51) = 4.8; p = .034; η2 = .08], and tending to make less errors of omission as
well [F (3,51) = 3.1; p = .08; η2 = .06]. No effects were found for reaction time.

NIH-PA Author Manuscript

On the Wisconsin Card Sorting Task, an allele by gender interaction effect reached trend
level on the total trials to first category measure [F (3,51) = 2.9; p = .09; η2 = .06]. Although
boys did not differ in performance on this measure, girls with the Met allele tended to
achieve better scores. On the measure of perseverative errors, individuals with the Met allele
tended to perform better that those with the Val allele [F (3,51) = 2.9; p = .097; η2 = .05],
and girls performed better than boys [F (3,51) = 10.8; p = .002; η2 = .18]. (FSIQ accounted
for almost 10% of the variance in this model as well: [F (3,51) = 5.4; p = .02; η2 = .097]).
However an allele by gender interaction was not found.

Discussion
We have demonstrated that the COMT Val158Met polymorphism affects prefrontal tissue
volumes in a gender-specific manner in children with VCFS. We did not find a genotype
effect or a genotype by gender effect on total frontal lobe or whole brain volume, suggesting
that this polymorphism affects prefrontal tissue differentially. This is consistent with
Am J Med Genet B Neuropsychiatr Genet. Author manuscript; available in PMC 2008 October 8.
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previous studies that have demonstrated that the COMT gene is expressed preferentially in
the prefrontal cortex (Chen et al., 2004; Matsumoto et al., 2003).
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Since we did not find allele by gender variation in age, psychiatric comorbidity or
medication use, it is unlikely that these factors account for our findings. Nonetheless, the
mechanism by which this polymorphism affects brain morphology in VCFS is not clear.
Due to the role that COMT plays in neurotransmission, most previous studies of non-VCFS
individuals have focused on the effect of the Val158Met polymorphism on prefrontal
function rather than anatomy (Diamond et al., 2004; Egan et al., 2001; Goldberg et al.,
2003). These studies have found that individuals who are homozygous for the Met allele
perform better on functional MRI – mediated tasks of working memory and executive
function, which depend primarily on prefrontal function, suggesting that higher levels of
available dopamine in the prefrontal cortex permit more efficient neurocognitive function.

NIH-PA Author Manuscript

A recent study focusing on the effect of this polymorphism on prefrontal anatomy in
individuals with schizophrenia did not find an effect of genotype on anatomy (Ho et al.,
2005). However, we do not know the effect of hemizygosity in individuals with VCFS.
Interestingly, in their longitudinal study of children with VCFS, Gothelf and colleagues
(2005) did not find COMT-related differences in prefrontal volume at their Time 1
assessment, but did find reduced prefrontal volumes in individuals hemizygous for the Met
allele at Time 2. This supports the notion that the dopaminergic environment in the brains of
patients with VCFS influences prefrontal morphology as well as function; however this
influence may be moderated by a complex interplay between other genes (Karayiorgou &
Gogos, 2004) and environmental factors (Grossman et al., 2003).
Our finding of differential effects of this polymorphism on subregions of the prefrontal
cortex was unexpected. Since dorsal PFC and orbital PFC differ in function and in
connectivity (Kaufer & Lewis, 1999), it is possible that each subregion requires different
levels of dopamine for optimal development. Insofar as the evidence for the expression of
COMT in the orbital PFC is less robust than that of the dorsal PFC, alterations in the
orbitofrontal cortex may also be due to an interaction between COMT and other genes that
are expressed in that subregion, or to a compensatory mechanism in response to COMTrelated changes in the dorsal PFC.
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The precise mechanism that underlies our findings of region-specific sexual dimorphism is
also not clear. Women have been shown to have lower COMT activity than men (Boudikova
et al., 1990; Floderus et al., 1981), presumably due to the downregulation of COMT by
estradiol (Jiang et al., 2003). Moreover, the COMT Val158Met polymorphism has been
reported to differentially affect gender in individuals with schizophrenia (Shifman et al.,
2002), anxiety (Enoch et al., 2002) and obsessive compulsive disorder (Alsobrook et al.,
2002; Karayiorgou et al., 1999). Gogos and colleagues (1998) further demonstrated sexually
dimorphic effects on dopamine levels and behaviors in COMT-deficient mice. Interestingly,
sexual dimorphism has also been reported in the volumes of the orbitofrontal cortex in
typical individuals and those with schizophrenia (Gur et al., 2002; Gur et al., 2004). In
general, these findings, taken together, support but do not explain our findings of gender by
allele differences in prefrontal volumes. It is likely that the COMT gene is either in
interaction or linkage disequilibrium with other genes to produce this effect. In addition,
gender differences in compensatory capacity (Gogos et al., 1998) may be contributing to our
findings as well.
Although these findings suggest that COMT and gender affect the morphology of the
network of brain regions that are involved in executive function, working memory and
response inhibition, we did not find that either allelic variation alone, or an allele by gender
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interaction, affected performance on our tasks of working memory or sustained attention.
We did find that individuals with the Met allele, particularly girls, tended to achieve higher
scores on a test of executive function. This finding is somewhat consistent with those of
Bearden and colleagues (Bearden et al., 2004), who found that individuals with VCFS who
were hemizygous for the Val allele exhibited poorer performance on tests of prefrontal
function, although Bearden et al.'s findings were more robust than ours. However, Bearden
and coworkers did not find a gender effect. The partial discrepancy in findings could be
explained by the differences in study instruments, as well as potential differences in sample
homogeneity and demographics (e.g. age). To the extent that our sample was more
heterogeneous than Bearden's sample, either according to age or cognitive function, it may
have been more difficult to detect a more robust effect of the COMT polymorphism on
neuropsychological function.
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It is possible (but unlikely) that the absence of a gender by allele effect on most tests of
neuropsychological function could have been due to the fact that these tests of executive
function have not been normed specifically on children with intellectual disabilities.
However, they have been used meaningfully and successfully in studies of individuals with
a wide range of disabilities, including fragile X syndrome (Loesch et al., 2003) and autism
(Joseph et al., 2005). Moreover, previous studies indicate that IQ accounts for a very modest
proportion of the variance in executive function skills (Crinella & Yu, 2000). It is more
likely that our findings result from the indirect association between genes and behavior.
Whereas brain morphology is an endophenotype (Almasy and Blangero, 2001) that may be
affected relatively directly by genotype, it is likely that specific behavioral phenotypes
result, instead, from a confluence of multiple genetic and environmental factors.
Accordingly, the effect of a specific gene on behavior is likely to be smaller and less direct
than its effect on brain morphology.
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Despite the indirect effect of genotype on behavioral phenotype, a relationship between
COMT and gender has been demonstrated in several disorders, as noted above. COMT
continues to be expressed throughout adolescence and adulthood (Maynard et al., 2003),
suggesting that this gene may mediate an abnormal neurodevelopmental process that unfolds
with age. Since our sample was relatively young (ranging in age from 6 to 15 years), it is
possible that the full effect of variation in the COMT gene may not have manifested itself.
Accordingly, we may not be able to discern potential clinical implications of this gender by
allele interaction until the children in our sample move into late adolescence or early
adulthood. This notion is consistent with the study cited above by Gothelf and colleagues
(2005), who found that COMT-related differences in cognition and psychiatric symptoms as
well as prefrontal volumes changed with age. Accordingly, we will be reassessing these
children in three years and may be able to identify at that time whether this interaction
confers susceptibility to psychiatric disorder.
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Figure 1.

Datapoints of the volumes of the dorsal prefrontal cortex, by allele (A = Met allele / G = Val
allele) and gender.
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Figure 2.

Datapoints of the volumes of the orbital prefrontal cortex, by allele (A = Met allele / G = Val
allele) and gender.
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